Immunotherapy of Head and Neck Cancer: Current and Future Considerations

Eu, D., & Lim, C. M. (2018). Managing Complications in Cancer Immunotherapy in Head and Neck Cancer. International Journal of Head and Neck Science, 2(3), 107-117. https://doi.org/10.6696/IJHNS.201809_2(3).0003
Ou, Y. C., & Chen, H. L. (2018). Immunotherapy in Prostate Cancer: Past, Current, and Future. 童綜合醫學雜誌, 12(1), 1-5. https://www.airitilibrary.com/Article/Detail?DocID=20713592-201806-201806280011-201806280011-1-5
Baba, Y., Fujii, M., Tokumaru, Y., & Kato, Y. (2012). Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer. Journal of Oncology, 2012(), 861-869-089. https://doi.org/10.1155/2012/986725
Nath, S. K., Simpson, D. R., Rose, B. S., & Sandhu, A. P. (2009). Recent Advances in Image-Guided Radiotherapy for Head and Neck Carcinoma. Journal of Oncology, 2009(), 395-404. https://doi.org/10.1155/2009/752135
Amar, A., Chedid, H. M., Rapoport, A., Dedivitis, R. A., Cernea, C. R., Brandão, L. G., & Curioni, O. A. (2012). Update of Assessment of Survival in Head and Neck Cancer after Regional Recurrence. Journal of Oncology, 2012(), 104-107-013. https://doi.org/10.1155/2012/154303